|
1. Beuerman, R.W. and L. Pedroza, Ultrastructure of the Human Cornea. Microscopy Research and Technique, 1996. 33(4): p. 320-335. 2. Chen, Z., et al., Biomaterials for Corneal Bioengineering. Biomedical Materials, 2018. 13(3): p. 27. 3. Palchesko, R.N., S.D. Carrasquilla, and A.W. Feinberg, Natural Biomaterials for Corneal Tissue Engineering, Repair, and Regeneration. Advanced Healthcare Materials, 2018. 7(16): p. 18. 4. Matthyssen, S., et al., Corneal Regeneration: A Review of Stromal Replacements. Acta Biomaterialia, 2018. 69: p. 31-41. 5. West-Mays, J.A. and D.J. Dwivedi, The Keratocyte: Corneal Stromal Cell with Variable Repair Phenotypes. International Journal of Biochemistry & Cell Biology, 2006. 38(10): p. 1625-1631. 6. Navaratnam, J., et al., Substrates for Expansion of Corneal Endothelial Cells towards Bioengineering of Human Corneal Endothelium. J Funct Biomater, 2015. 6(3): p. 917-45. 7. Stuart, A.J., et al., Descemet's Membrane Endothelial Keratoplasty (DMEK) Versus Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for Corneal Endothelial Failure (Review). Cochrane Database of Systematic Reviews, 2018(6): p. 37. 8. Janson, B.J., et al., Glaucoma-Associated Corneal Endothelial Cell Damage: A Review. Survey of Ophthalmology, 2018. 63(4): p. 500-506. 9. Murphy, C., et al., Prenatal and Postnatal Cellularity of the Human Cornal Endothelium - A Quantitative Histologic-Study. Investigative Ophthalmology & Visual Science, 1984. 25(3): p. 312-322. 10. Bourne, W.M., L.R. Nelson, and D.O. Hodge, Central corneal endothelial cell changes over a ten-year period. Investigative Ophthalmology & Visual Science, 1997. 38(3): p. 779-782. 11. Smolin, G., R.A. Thoft, and C.H. Dohlman, Endothelial Function. The Cornea: Scientific Foundations and Clinical Practice, 1994. 3: p. 635-643. 12. Borboli, S. and K. Colby, Mechanisms of Disease: Fuchs' Endothelial Dystrophy. Ophthalmology Clinics, 2002. 15(1): p. 17-25. 13. Schrittenlocher, S., B. Bachmann, and C. Cursiefen, Impact of Donor Tissue Diameter on Postoperative Central Endothelial Cell Density in Descemet Membrane Endothelial Keratoplasty. Acta Ophthalmologica, 2019. 97(4): p. E618-E622. 14. Lai, J.Y., et al., Characterization of Cross-Linked Porous Gelatin Carriers and Their Interaction with Corneal Endothelium: Biopolymer Concentration Effect. Plos One, 2013. 8(1): p. 12. 15. Watanabe, R., et al., A Novel Gelatin Hydrogel Carrier Sheet for Corneal Endothelial Transplantation. Tissue Engineering Part A, 2011. 17(17-18): p. 2213-2219. 16. Rahman, I., S.K. Biswas, and P.A. Kirkham, Regulation of Inflammation and Redox Signaling by Dietary Polyphenols. Biochemical Pharmacology, 2006. 72(11): p. 1439-1452. 17. Maheshwari, R.K., et al., Multiple Biological Activities of Curcumin: A Short Review. Life Sciences, 2006. 78(18): p. 2081-2087. 18. Zhang, N., et al., Anti-Inflammatory Effect of Curcumin on Mast Cell-Mediated Allergic Responses in Ovalbumin-Induced Allergic Rhinitis Mouse. Cellular Immunology, 2015. 298(1-2): p. 88-95. 19. Liu, X.F., et al., Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review. Frontiers in Pharmacology, 2017. 8: p. 13. 20. Jensen, D.K., et al., Design of an Inhalable Dry Powder Formulation of DOTAP-modified PLGA Nanoparticles Loaded with siRNA. Journal of Controlled Release, 2012. 157(1): p. 141-148. 21. Sahana, D.K., et al., PLGA Nanoparticles for Oral Delivery of Hydrophobic Drugs: Influence of Organic Solvent on Nanoparticle Formation and Release Behavior In Vitro and In Vivo using Estradiol as a Model Drug. Journal of Pharmaceutical Sciences, 2008. 97(4): p. 1530-1542. 22. Khademi, F., et al., Formulation and Optimization of a New Cationic Lipid-Modified PLGA Nanoparticle as Delivery System for Mycobacterium tuberculosis HspX/EsxS Fusion Protein: An Experimental Design. Iranian Journal of Pharmaceutical Research, 2019. 18(1): p. 446-458. 23. Makadia, H.K. and S.J. Steven, Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier. Polymers (Basel), 2011. 3(3): p. 1377-1397. 24. Siegel, S.J., et al., Effect of Drug Type on the Degradation Rate of PLGA Matrices. European Journal of Pharmaceutics and Biopharmaceutics, 2006. 64(3): p. 287-293. 25. Tapeinos, C., M. Battaglini, and G. Ciofani, Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. Journal of Controlled Release, 2017. 264: p. 306-332. 26. Z., L. and L. Z., Lipid–Polymer Hybrid Nanoparticles: Synthesis, Characterization and Applications. Nano LIFE, 2010. 01(01n02): p. 163-173. 27. Dave, V., et al., Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications. Journal of Microbiological Methods, 2019. 160: p. 130-142. 28. Reis, C.P., et al., Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine-Nanotechnology Biology and Medicine, 2006. 2(1): p. 8-21. 29. Zhang, L.F., et al., Self-Assembled Lipid-Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform. Acs Nano, 2008. 2(8): p. 1696-1702. 30. Xu, H., et al., An Efficient Trojan Delivery of Tetrandrine by Poly(N-vinylpyrrolidone)-block-Poly(Epsilon-Caprolactone) (PVP-b-PCL) Nanoparticles Shows Enhanced Apoptotic Induction of Lung Cancer Cells and Inhibition of its Migration and Invasion. Int J Nanomedicine, 2014. 9: p. 231-42. 31. Seo, S.B., et al., Novel Multifunctional PHDCA/PEI Nano-Drug Carriers for Simultaneous Magnetically Targeted Cancer Therapy and Diagnosis via Magnetic Resonance Imaging. Nanotechnology, 2007. 18(47). 32. Skoog, D.A., F.J. Holler, and S.R. Crouch, Principles of Instrumental Analysis, 6th ed. brooks/cole:belmont. 2007.
|